Human Arginase1 Complexed with Bicyclic Inhibitor Compound 10

Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer Immunotherapy.

10% MMT (pH 7.0) 0.1 M ammonium formate, 16-22% PEG 8000

AGONIST, ARG (ARGINASE), BICYCLIC, IMMUNOTHERAPY, METALLOENZYME, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR complex